Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - OPERATING EXPENSES
Operating Expenses RARE - Ultragenyx Pharmaceutical Inc.
958 M
LAST VALUE
15.59%
2 YEAR CAGR
17.84%
5 YEAR CAGR
40.36%
10 YEAR CAGR